-
REAL-WORLD COMPARATIVE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A SAUDI TERTIARY-CENTRE COHORT STUDY
Aug 11, 2026, 17:16 PM -
ARE AI-ASSISTED EVIDENCE REVIEWS HTA-READY? A TARGETED LITERATURE REVIEW USING THE ELEVATE-GENAI QUALITY FRAMEWORK
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PUBLIC-FUNDED BIENNIAL LOW-DOSE CT LUNG CANCER SCREENING IN TAIWAN: A RISK-GROUP MARKOV ANALYSIS
Aug 11, 2026, 17:16 PM -
FROM JCA EVIDENCE PACKAGE TO NATIONAL REIMBURSEMENT: HOW EUROPEAN HTA BODIES ASSESS INDIRECT TREATMENT COMPARISONS
Aug 11, 2026, 17:16 PM -
CLINICAL QUALITY INDICATORS IN ORTHOPEDIC CARE IN TURKIYE: A POLICY ANALYSIS AND FRAMEWORK FOR REFINEMENT
Aug 11, 2026, 17:16 PM -
MINIMAL SYMPTOM EXPRESSION IN GENERALIZED MYASTHENIA GRAVIS TREATED WITH TRADITIONAL THERAPIES: A REAL-WORLD BENCHMARK FROM MYREALWORLD-MG
Aug 11, 2026, 17:16 PM -
BEYOND CLINICAL BENEFIT: APPROACHES TO INCORPORATING SOCIETAL VALUE IN HTA AND REIMBURSEMENT DECISION-MAKING - A TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
COSMETOVIGILANCE KNOWLEDGE, ATTITUDES, AND HEALTH ANXIETY AMONG UNIVERSITY STUDENTS: A QUESTIONNAIRE-BASED CROSS-SECTIONAL STUDY IN HUNGARY
Aug 11, 2026, 17:16 PM -
ANTIBIOTIC USE AND EXPENDITURE IN TUNISIA: INSIGHTS FROM THE WHO AWARE CLASSIFICATION
Aug 11, 2026, 17:16 PM -
A MULTI-SCALE CLASSICAL AI FRAMEWORK FOR SYSTEM-LEVEL VALUE ASSESSMENT OF HEALTH TECHNOLOGY ADOPTION
Aug 11, 2026, 17:16 PM -
TOWARDS OPTIMIZED CAR-T CELL THERAPY MANAGEMENT: CURRENT OPERATIONAL AND REGULATORY CHALLENGES FROM A PROCESS PERSPECTIVE
Aug 11, 2026, 17:16 PM -
ECONOMIC VALUE OF PERSONALIZED LIFESTYLE INTERVENTIONS: MAPPING THE EVIDENCE
Aug 11, 2026, 17:16 PM -
REFILL INTERVALS AS MARKERS OF CALENDAR-TIME CYCLE TIMING IN CYCLIC ORAL ANTICANCER THERAPY: VALIDATION USING AN INTRAVENOUS CYCLE ANCHOR IN GASTRIC CANCER REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
A TABULAR FOUNDATION MODEL FOR OUTREACH TARGETING: PREDICTING SENIOR EMPLOYMENT PROGRAM WILLINGNESS AMONG OLDER NONPARTICIPANTS USING WELFARE SURVEY DATA
Aug 11, 2026, 17:16 PM -
EVALUATION OF MEDICINES FROM WHO MODEL LIST OF ESSENTIAL MEDICINES WITHIN NATIONAL HTA PROCEDURE IN UKRAINE: FINDINGS AND IMPLICATIONS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF LIPOSOMAL IRINOTECAN IN COMBINATION WITH OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN (NALIRIFOX) FOR THE FIRST-LINE TREATMENT OF ADULT PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE PANCREAS IN GREECE
Aug 11, 2026, 17:16 PM -
MORTALITY, DISEASE BURDEN AND HEALTHCARE RESOURCE USE IN PATIENTS WITH TRANSTHYRETIN AMYLOIDOSIS WITH CARDIAC INVOLVEMENT IN SPAIN: RESULTS FROM THE OVERTTURE GLOBAL STUDY
Aug 11, 2026, 17:16 PM -
TREAT NOW, PROVE LATER? EU5 PAYER PERSPECTIVES ON PRE-SYMPTOMATIC GENE THERAPY FOR HUNTINGTON'S DISEASE
Aug 11, 2026, 17:16 PM -
MIND THE GAP: INEQUITIES IN MARKET ACCESS TIMELINES ACROSS EUROPE
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND OUTCOMES IN PULMONARY ARTERIAL HYPERTENSION: EVIDENCE FROM A TERTIARY CENTER IN ARGENTINA
Aug 11, 2026, 17:16 PM
